• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC ARCHITECT C8000 SYSTEM; AUTOMATED CHEMISTRY ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC ARCHITECT C8000 SYSTEM; AUTOMATED CHEMISTRY ANALYZER Back to Search Results
Catalog Number 01G06-11
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Code Available (3191)
Event Date 06/13/2018
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.(b)(4).The patient received iv fluids.Concomitant medical products and therapy dates ict diluent ln 02p32-11 ln 79765un18, cc creatinine ln 03l81-32 ln 79769un18 architect c16000 analyzer ln 3l77-01 sn (b)(4).
 
Event Description
The customer observed erratic potassium and creatinine results while using the architect c8000 analyzer.The following data was provided for the same patient.Potassium (k) (normal range 3.5 to 5.1 mmol/l): sid (b)(6) (first draw) using analyzer sn (b)(4) initial 7.8 mmol/l, repeat 5.3, 5.5 mmol/l; sid (b)(6) (second draw) initial using analyzer sn (b)(4) 3.8 mmol/l, repeat using analyzer sn (b)(4) 3.7 mmol/l.Creatinine (crea) (normal range 0.72 to 1.25 mg/dl): sid (b)(6) (first draw) using analyzer sn (b)(4) initial 6.08 mg/dl, repeat 2.80, 3.22 mg/dl; sid (b)(6) (second draw) initial using analyzer sn (b)(4) 0.82 mg/dl, repeat using analyzer sn (b)(4) 0.82 mg/dl.The patient was in the emergency room (ed) and received iv fluids between the draws of the first and second specimens to reduce the potassium levels and creatinine.Impact to patient health was unknown.
 
Manufacturer Narrative
The customer had tightened the screw on the analyzer mixer [part 09d59-02], however the customer replaced the mixer to address the issue.No additional discrepant results generated the analyzer after the mixer was replaced.This was determined to be the likely cause for the issue.Evaluation of the customer issue included a complaint text review, a search for similar complaints, device history review, instrument service review, and labeling review.Returns were not available.No adverse trend was identified for the customer issue.Device history review for part did not identify any issues that may have caused the customer issue.Analyzer service history was reviewed and no contributing factors were found.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics evaluation, no systemic issue was identified and no product deficiency was found.Section 11.Concomitant medical products ict diluent ln 02p32-11 ln 79765un18 cc creatinine ln 03l81-32 ln 79769un18 architect c16000 analyzer ln 3l77-01 sn (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT C8000 SYSTEM
Type of Device
AUTOMATED CHEMISTRY ANALYZER
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
MDR Report Key7660835
MDR Text Key113504317
Report Number1628664-2018-00264
Device Sequence Number1
Product Code JJE
UDI-Device Identifier00380740000509
UDI-Public00380740000509
Combination Product (y/n)N
PMA/PMN Number
K980367
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 07/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/03/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number01G06-11
Was Device Available for Evaluation? Yes
Date Manufacturer Received07/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age19 YR
-
-